EMIG represents its Members on the issues directly affecting their businesses. We have a number of Special Interest Groups (SIGs) that inform our position on a wide range of issues from regulation and research to pricing and orphan diseases.

Our understanding of the unique issues affecting small to medium-sized companies allows EMIG to make a valuable and informed representations in discussions with government and policy makers regarding the key issues affecting the sector.

EMIG has the following Special Interest Groups:

  • Business Development Group
  • CEO/GM Group
  • Digital Group
  • Finance Group
  • HR Group
  • Legal Group - EU/UK
  • Market Access/Orphan Medicines Group¬†
  • Medical Directors' Forum
  • EMIG Northern Ireland
  • Regulatory Group
  • EMIG Scotland
  • EMIG Wales
Cookie Policy | Terms and Conditions | Privacy Policy
Copyright © Ethical Medicines Industry Group 2013 | Ethical Medicines Industry Group (EMIG), 120 Pall Mall, London SW1Y 5EA